171 related articles for article (PubMed ID: 29701429)
1. Pharmacotherapy and ROP: Going Back to the Basics.
Shulman JP; Hartnett ME
Asia Pac J Ophthalmol (Phila); 2018; 7(3):130-135. PubMed ID: 29701429
[TBL] [Abstract][Full Text] [Related]
2. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
Cayabyab R; Ramanathan R
Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
[TBL] [Abstract][Full Text] [Related]
3. [Be cautious to treat retinopathy of prematurity with anti-vascular endothelial growth factor pharmacotherapy].
Liang JH; Cheng Y
Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):246-249. PubMed ID: 30982286
[TBL] [Abstract][Full Text] [Related]
4. New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.
Ryu J
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955664
[TBL] [Abstract][Full Text] [Related]
5. Anti-Vascular Endothelial Growth Factor and the Evolving Management Paradigm for Retinopathy of Prematurity.
Darwish D; Chee RI; Patel SN; Jonas K; Ostmo S; Campbell JP; Chiang MF; Chan RVP
Asia Pac J Ophthalmol (Phila); 2018; 7(3):136-144. PubMed ID: 29808629
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Sankar MJ; Sankar J; Chandra P
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
[TBL] [Abstract][Full Text] [Related]
8. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
Eldweik L; Mantagos IS
Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
[TBL] [Abstract][Full Text] [Related]
9. Understanding retinopathy of prematurity: update on pathogenesis.
Rivera JC; Sapieha P; Joyal JS; Duhamel F; Shao Z; Sitaras N; Picard E; Zhou E; Lachapelle P; Chemtob S
Neonatology; 2011; 100(4):343-53. PubMed ID: 21968165
[TBL] [Abstract][Full Text] [Related]
10. [Advances in Retinopathy of Prematurity].
Xu XX; Wu YJ; Wu HY; Hu YX; Cheng Y; Yan L; Rao J; Wu N; Wu XR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):261-266. PubMed ID: 31060684
[TBL] [Abstract][Full Text] [Related]
11. Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity.
Tsang JKW; Liu J; Lo ACY
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484463
[TBL] [Abstract][Full Text] [Related]
12. Hot Topics in Retinopathy of Prematurity.
Tsui I; Chu A
Pediatr Ann; 2017 Nov; 46(11):e415-e422. PubMed ID: 29131921
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
Kaempfen S; Neumann RP; Jost K; Schulzke SM
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011893. PubMed ID: 29499081
[TBL] [Abstract][Full Text] [Related]
14. Retinopathy of prematurity.
Dammann O; Hartnett ME; Stahl A
Dev Med Child Neurol; 2023 May; 65(5):625-631. PubMed ID: 36408783
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
[TBL] [Abstract][Full Text] [Related]
16. [VEGF antibodies as therapy for retinopathy of prematurity].
Oberacher-Velten IM; Helbig H
Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.
Dai C; Webster KA; Bhatt A; Tian H; Su G; Li W
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062733
[TBL] [Abstract][Full Text] [Related]
18. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
[TBL] [Abstract][Full Text] [Related]
19. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk.
Adams GG; Bunce C; Xing W; Butler L; Long V; Reddy A; Dahlmann-Noor AH
BMJ Open; 2017 Mar; 7(3):e013366. PubMed ID: 28325857
[TBL] [Abstract][Full Text] [Related]
20. Retinopathy of Prematurity: Anti-VEGF treatment for ROP: which drug and what dose?
Wallace DK
J AAPOS; 2016 Dec; 20(6):476-478. PubMed ID: 27826044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
